Phase 2 Study for the Treatment of Superficial Lipomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Patricia S. Walker, M.D., Ph.D.
Kythera Biopharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gary D. Monheit, M.D.
Birmingham, Alabama, United States
- Stacy R. Smith
San Diego, California, United States
- Steven Grekin, D.O.
Warren, Michigan, United States
- Joel Schlessinger, M.D.
Omaha, Nebraska, United States
- David J. Goldberg, M.D.
Westwood, New Jersey, United States
- Neil S. Sadick, M.D.
New York, New York, United States
- Michael H. Gold, M.D.
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 Aug 2008
- Completion
- 31 Jan 2010
- Last update posted
- 14 Jan 2016
- Registered enrollment
- 62
- Registry id
- NCT00608842
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.